298 studies found for:    cholangiocarcinoma
Show Display Options
Rank Status Study
1 Active, not recruiting A Phase II Study of Cabozantinib (XL-184) Monotherapy in Patients With Advanced Cholangiocarcinoma After Progression on First or Second Line Systemic Therapy
Conditions: Bile Duct Cancer;   Intrahepatic Cholangiocarcinoma;   Cholangiocarcinoma of the Extrahepatic Bile Duct
Intervention: Drug: Cabozantinib
2 Completed
Has Results
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Radiation: CT scan
3 Not yet recruiting Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: FOLFIRINOX
4 Unknown  Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Condition: Advanced Intrahepatic Cholangiocarcinoma
Intervention: Drug: Calcitriol
5 Unknown  Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Everolimus
6 Completed S-1 and Photodynamic Therapy in Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: S-1 Chemotherapy;   Procedure: Photodynamic therapy;   Procedure: Systemic chemotherapy except S-1
7 Recruiting Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Conditions: Unresectable Cholangiocarcinoma;   Biliary Obstruction;   Stent Obstruction;   Biliary Stricture
Intervention: Procedure: Photodynamic Therapy
8 Unknown  Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
Condition: Unresectable Hilar Cholangiocarcinoma
Intervention: Device: biliary stent
9 Completed Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Capecitabine
10 Recruiting Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Other: exposure to different risk factors and molecular assessment
11 Completed Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
Conditions: Cholangiocarcinoma;   Gallbladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin
12 Unknown  Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Drainage;   Surgery
Intervention: Procedure: Preoperative biliary drainage
13 Withdrawn Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
Condition: Cholangiocarcinoma
Intervention:
14 Recruiting A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Conditions: Unresectable Intrahepatic Cholangiocarcinoma;   Resectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgery;   Radiation: Radiation
15 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
16 Recruiting International Registry on Cholangiocarcinoma Treatment
Condition: Cholangiocarcinoma
Intervention: Drug: Doxorubicin
17 Recruiting Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Condition: Cholangiocarcinoma
Intervention: Other: Observation data collection study.
18 Terminated Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: WST11
19 Recruiting Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Nab-Paclitaxel and Gemcitabine
20 Unknown  Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Condition: Cholangiocarcinoma
Intervention: Drug: RAD001

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years